Moleculin Biotech to Participate in Advances in Oncology Panel at the 2026 Maxim Growth Summit
Go back to Moleculin Biotech to Participate in Advances in Oncology Panel at the 2026 Maxim Growth Summit| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 9.10 -0.17 (1.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.27 | 52 Week High | $9.58 | |||
| Open | $9.41 | 52 Week Low | $2.34 | |||
| Day High | $10.24 | P/E | N/A | |||
| Day Low | $8.58 | EPS | $-0.34 | |||
| Volume | 61,279 | |||||



